Type B Aortic Dissection: Techniques, perspectives, and decision-making.
Vol. 21, no 11

Type B Aortic Dissection: Techniques, perspectives, and decision-making.

In This Issue

Guest Chief Medical Editors Christoph A. Nienaber, MD, & Grace J. Wang, MD, share an overview of our latest issue, which focuses on decision-making in type B aortic dissection. Plus, additional features on the use of radial access & the process of venous stent engineering.

COVER STORIES

Dissection Retrospective: Progress Since the INSTEAD Trial

Prof. Christoph A. Nienaber offers his view on thoracic aortic dissection with lessons learned from the INSTEAD trial, which evaluated TEVAR & optimal medical therapy for TBAD.?

The STABILISE Technique for Treatment of Acute/Subacute Type B Dissections

Germano Melissano, MD, & Daniele Mascia, MD, provide an in-depth look at the STABILISE technique, an evolution of PETTICOAT, to treat acute and subacute TBAD.

Embolization Techniques for False Lumen Treatment

Drs. Patrick R. Vargo, Adam Daly, & Eric E. Roselli offer their approach to treating the false lumen during TEVAR using balloon fracture fenestration and direct false lumen embolization.

Managing Ruptured Acute and Chronic Aortic Dissections

Drs. Ryan Gouveia e Melo, Tarek Hamwi, & Nikolaos Tsilimparis describe cases of acute and chronic aortic dissection ruptures to illustrate the challenges encountered and the various techniques utilized for the treatment of this challenging clinical problem.

The Importance of “Backdoor” Treatment to Close Distal Entry Tears in Chronic Type B Aortic Dissection

Konstantinos Spanos, MD; Fiona Rohlffs, MD; Giuseppe Panuccio, MD; Ahmed Eleshra, MD; & Tilo K?lbel, MD, discuss the evolution of the candy-plug and knickerbocker techniques for distal false lumen occlusion, as well as the timing of intervention and patient anatomy considerations.

Medical Management of Acute and Chronic Type B Aortic Dissection

Drs. Christina L. Fanola & Eric Isselbacher discuss the clinical presentation and complications of TBAD, medical management in the acute setting and over the long term, and the use of fluoroquinolones in chronic TBAD.

Panel Discussion: Decision-Making for Type B Aortic Dissection

Tilo K?lbel, MD; Tara M. Mastracci, MD; Christoph A. Nienaber, MD; Germano Melissano, MD; Daniele Mascia, MD; and Eric E. Roselli, MD, offer their insights for the treatment of uncomplicated TBAD.

RADIAL ACCESS

Ask the Experts: What Dedicated Radial Technologic Advancement Would Be Most Helpful in Your PAD Practice?

Robert J. Beaulieu, MD; William E. Beckerman, MD; and Yulanka Castro-Dominguez, MD, describe their ideal device sheath size and length for transradial access in peripheral interventions.?

Ask the Experts: What Are the Most Common Obstacles to Success During Radial Access, and How Can They Be Avoided?

Anastasia Hadjivassiliou, MBBS; Anna Luisa Kühn, MD; and David O’Connor, MD, each provide their thoughts on the most common obstacles when performing radial access in the peripheral and neurointerventional settings.

FEATURED TECHNOLOGY

First Reports on the Novel InThrill Thrombectomy System | Sponsored by Inari Medical

Drs. Vivek Kumar and Pavan Khanna share case examples using the InThrill Thrombectomy System as a lytic-free first-line treatment for rapid removal of thrombus outside the iliofemoral region.?| Sponsored by Inari Medical

MEDICAL AFFAIRS CORNER

Venous Stenting: A Behind-the-Scenes Look at the Trial Data | Sponsored by Medtronic

In Medtronic’s Medical Affairs Corner, Dr. Erin Murphy outlines the current state of venous stenting, reviewing the 4 major completed venous IDE trials & what the data mean for obstructive venous disease. | Sponsored by Medtronic

DEPARTMENTS

Engineer’s Corner: Perspectives in Venous Stenting

We brought together medical device engineers from BD, Boston Scientific Corporation, Cook Medical, and Medtronic in a collaborative roundtable to discuss how their efforts translate to venous practice.

An Interview With Kak Khee Yeung, MD, PhD, FEBVS

In our recent interview with Kak Khee Yeung, MD, she talks about her work developing a biobank with live patient cells to understand AAA pathophysiology, the capabilities of AI for personalized medicine in vascular care, and more.

要查看或添加评论,请登录

Endovascular Today的更多文章

社区洞察

其他会员也浏览了